Aspirin for Primary Prevention of Cardiovascular Events - Abdelaziz, Hesham K.; Saad, Marwan; Pothineni, Naga Venkata K.; Megaly, Michael; Potluri, Rahul; Saleh, Mohammed; Kon, David Lai Chin; Roberts, David H.; Bhatt, Deepak L.; Aronow, Herbert D.; Abbott, J. Dawn; Mehta, Jawahar L. (Journal of the American College of Cardiology, 2019)
Keywords: Age; Angina pectoris; Anti-Inflammatory Agents, Non-Steroidal - administration & dosage; Anti-Inflammatory Agents, Non-Steroidal - adverse effects; Aspirin; Aspirin - administration & dosage; Aspirin - adverse effects; Bias; Bleeding; Cancer; Cardiology; Cardiovascular; Cardiovascular diseases; Cardiovascular Diseases - diagnosis; Cardiovascular Diseases - mortality; Cardiovascular Diseases - prevention & control; cardiovascular events; Cerebral infarction; Clinical trials; Death; Diabetes; Diabetic retinopathy; Disease prevention; Gastrointestinal Hemorrhage - chemically induced; Gastrointestinal Hemorrhage - diagnosis; Gastrointestinal Hemorrhage - mortality; Health risk assessment; Humans; Ischemia; Mortality; Myocardial infarction; primary prevention; Primary Prevention - methods; Primary Prevention - trends; Randomized Controlled Trials as Topic - methods; Stroke; Studies; Transient ischemic attack; Vitamin E; United Kingdom--UK; United States--US; Europe; Japan; cardiovascular events; CVD; MACE; primary prevention; aspirin; MI; TIA; cardiovascular disease; myocardial infarction; transient ischemic attack; major adverse cardiovascular events